Overview

Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Since a new generation of femtosecond lasers became available for cataract surgery in 2009, the use of this image-guided system has provided several benefits, including a reduction in phacoemulsification energy by prefragmentation of the crystalline lens, and the potential advantages of more precise corneal incisions and capsulotomy formation. However, as with any new surgical technique, femtosecond laser cataract surgery also has potential complications. Intraoperative miosis is one of the most common intraoperative complications of femtosecond laser-assisted cataract surgery, with a reported prevalence ranging from 9.5 to 32.0%.8 Significant pupillary constriction necessitates the removal of the anterior capsule flap, fragmented nucleus and remaining cortex, which is potentially associated with a higher rate of surgery-related complications.
Phase:
N/A
Details
Lead Sponsor:
Sun Yat-sen University
Collaborator:
Ministry of Health, China
Treatments:
Bromfenac
Dinoprostone
Ophthalmic Solutions
Pharmaceutical Solutions